3.8 Article

Isolation and characterization of the human secretogranin II gene promoter

期刊

MOLECULAR BRAIN RESEARCH
卷 75, 期 1, 页码 8-15

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/S0169-328X(99)00269-7

关键词

granin; cyclic AMP response element-binding protein; luciferase reporter gene, neuroblastoma

资金

  1. NIDDK NIH HHS [DK-40593] Funding Source: Medline

向作者/读者索取更多资源

The goal of this study was to isolate and functionally characterize the human secretogranin II (SgII) gene promotor. SgII is a member of the granin family of proteins which are selectively expressed in neurosecretory cells. The human SgII: promoter contains a consensus TATA box and cyclic AMP response element (CRE) 35 and 74 bp upstream of the transcription start site, respectively, elements also found in the mouse and rat SgII gene promoters. Transfection studies showed that 869 bp of the human SgII promoter were sufficient to confer cell type-specific expression of an SgII promoter-luciferase reporter gene in neurosecretory PC-12, GH and BE(2)-M17 cells. The activity of the human SgII promoter was also compared in three N-type, human neuroblastoma cell lines [BE(2)-M17, SMS-KAN and SH-SY5Y], which differ markedly in the level of SgII expression. SgII promoter activities in the neuroblastoma cell lines correlated not only with the levels of SgII but also the levels of the cyclic AMP response element-binding protein CREB which were highest in BE(2)-M17 cells and lowest in SH-SY5Y cells. To establish that the activity of the human SgII promoter in these neuroblastoma cell lines is dependent on the level of CREB, rat CREB was overexpressed in SH-SY5Y cells. SgII promoter activity was up to 8-fold higher in SH-SY5Y cells overexpressing CREB. These results suggest that SgII expression is a marker for neuronal differentiation in human neuroblastoma cell lines and is dependent on the level of CREB expression. (C) 2000 Elsevier Science B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据